Burcon NutraScience Corporation (TSX:BU)
Canada
· Delayed Price · Currency is CAD 3.000
-0.310 (-9.37%)
Jul 7, 2025, 3:59 PM EDT
Burcon NutraScience Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 0.38 | 0.18 | 0.36 | 0.17 | 0.26 | Upgrade
| |
Revenue Growth (YoY) | 106.88% | -49.34% | 112.23% | -33.70% | 730.75% | Upgrade
|
Cost of Revenue | 1.25 | - | - | - | 0.79 | Upgrade
|
Gross Profit | -0.87 | 0.18 | 0.36 | 0.17 | -0.53 | Upgrade
|
Selling, General & Admin | 3.9 | 3.74 | 3.94 | 4.53 | 3.8 | Upgrade
|
Research & Development | 2.92 | 3.46 | 3.95 | 3.38 | 0.53 | Upgrade
|
Operating Expenses | 6.83 | 7.2 | 7.89 | 7.91 | 4.33 | Upgrade
|
Operating Income | -7.7 | -7.02 | -7.53 | -7.74 | -4.86 | Upgrade
|
Interest Expense | -0.63 | -0.41 | -0.2 | -0.06 | -0.7 | Upgrade
|
Interest & Investment Income | 0.08 | 0.09 | 0.41 | 0.41 | 0.45 | Upgrade
|
Earnings From Equity Investments | - | - | -5.5 | -4.29 | -2.42 | Upgrade
|
Currency Exchange Gain (Loss) | 0.02 | -0 | 0 | -0 | -0 | Upgrade
|
Other Non Operating Income (Expenses) | -0.03 | -0.1 | -0.27 | 0.11 | 0.27 | Upgrade
|
EBT Excluding Unusual Items | -8.26 | -7.45 | -13.08 | -11.59 | -7.26 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | -7.99 | 0.96 | 6.38 | Upgrade
|
Other Unusual Items | - | - | -4.36 | 0.34 | 0.26 | Upgrade
|
Pretax Income | -8.26 | -7.45 | -25.42 | -10.29 | -0.62 | Upgrade
|
Income Tax Expense | - | - | -0.06 | -0.03 | - | Upgrade
|
Net Income | -8.26 | -7.45 | -25.36 | -10.26 | -0.62 | Upgrade
|
Net Income to Common | -8.26 | -7.45 | -25.36 | -10.26 | -0.62 | Upgrade
|
Shares Outstanding (Basic) | 8 | 6 | 5 | 5 | 5 | Upgrade
|
Shares Outstanding (Diluted) | 8 | 6 | 5 | 5 | 5 | Upgrade
|
Shares Change (YoY) | 28.83% | 11.65% | 0.13% | 5.54% | 30.35% | Upgrade
|
EPS (Basic) | -1.06 | -1.23 | -4.67 | -1.89 | -0.12 | Upgrade
|
EPS (Diluted) | -1.06 | -1.23 | -4.67 | -1.89 | -0.12 | Upgrade
|
Free Cash Flow | -5.82 | -5.9 | -6.38 | -5.97 | -3.93 | Upgrade
|
Free Cash Flow Per Share | -0.74 | -0.97 | -1.17 | -1.10 | -0.76 | Upgrade
|
Gross Margin | -228.31% | 100.00% | 100.00% | 100.00% | -203.87% | Upgrade
|
Operating Margin | -2018.75% | -3807.23% | -2067.88% | -4512.57% | -1877.56% | Upgrade
|
Profit Margin | -2166.98% | -4038.96% | -6969.87% | -5982.59% | -238.74% | Upgrade
|
Free Cash Flow Margin | -1525.02% | -3202.50% | -1751.91% | -3478.73% | -1518.48% | Upgrade
|
EBITDA | -7.43 | -6.8 | -7.29 | -7.58 | -4.73 | Upgrade
|
D&A For EBITDA | 0.26 | 0.22 | 0.24 | 0.16 | 0.12 | Upgrade
|
EBIT | -7.7 | -7.02 | -7.53 | -7.74 | -4.86 | Upgrade
|
Revenue as Reported | - | - | - | - | 0.26 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.